Cerebral dysfunction in patients with acute myocardial infarction
https://doi.org/10.23873/2074-0506-2023-15-4-507-514
Abstract
Background. The article discusses the features of one of the complications of acute myocardial infarction – cerebral dysfunction, which negatively affects the quality of life of patients, worsens the disease prognosis, increases the hospital length of stay and the risk of death. The presence of cerebral disorders in patients with acute myocardial infarction causes difficulties in the choice of therapeutic tactics, including the decision on myocardial revascularization. The identification of predictive factors for cerebral deficiency in acute myocardial infarction and the development of an algorithm for the management of such patients is an urgent task of today medicine.
Aim. To study the features of cerebral dysfunction in patients with myocardial infarction according to contemporary Russian and foreign literature sources. To create an algorithm for the diagnosis and treatment of cerebral dysfunction in patients with acute myocardial infarction.
Material and methods. Patients with acute myocardial infarction who developed cerebral dysfunction in the acute period of the disease were examined.
Conclusion. Timely diagnosis, antiplatelet therapy, emergency reperfusion therapy in the acute period of myocardial infarction, as well as preventive measures reduce the development of cerebral complications, improve the results of treatment of patients with myocardial infarction, reduce the number of inpatient treatment days, as well as improve the long term prognosis.
About the Authors
N. A. MuradyanRussian Federation
Nina A. Muradyan - Cardiologist, Researcher of the Urgent Cardiology Department for Patients with Myocardial Infarction.
3 Bolshaya Sukharevskaya Sq., Moscow 129090
I. M. Kuzmina
Russian Federation
Irina M. Kuzmina - Cand. Sci. (Med.), Cardiologist, Head of the Scientific Department of Urgent Cardiology for Patients with Myocardial Infarction.
3 Bolshaya Sukharevskaya Sq., Moscow 129090
T. R. Gvindzhiliya
Russian Federation
Tamara R. Gvindzhiliya - Junior Researcher of the Cardiology Department for Patients with Myocardial Infarction.
3 Bolshaya Sukharevskaya Sq., Moscow 129090
V. M. Balanyan
Russian Federation
Vagram M. Balanyan - Cardiovascular Surgeon of Cardiac Surgery Department No. 1.
3 Bolshaya Sukharevskaya Sq., Moscow 129090
K. A. Popugaev
Russian Federation
Konstantin A. Popugaev - Professor of the Russian Academy of Sciences, Dr. Sci. (Med.), Deputy Director – Head of the Regional Vascular Center.
3 Bolshaya Sukharevskaya Sq., Moscow 129090
References
1. Kim IV, Bochkareva EV, Varakin YY. Unity of approaches to the prevention of coronary heart disease and cerebrovascular diseases. Preventive medicine. 2015;6:24–33. (In Russ.). https://doi.org/10.17116/profmed201518624-33
2. Collet JP, Thiele H, Barbato E, Barthélémy O, Bauersachs J, Bhatt DL, et al. 2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Eur Heart J. 2021;42(14):1289–1367. PMID: 32860058 https://doi.org/10.1093/eurheartj/ehaa575
3. de Castillo LLC, Diestro JDB, Tuazon CAM, Sy MCC, Añonuevo JC, San Jose MCZ. Cardiocerebral infarction: a single institutional series. J Stroke Cerebrovasc Dis. 2021;30(7):105831. PMID: 33940364 https://doi.org/10.1016/j.jstrokecerebrovasdis.2021.105831
4. Boyanpally A, Cutting S, Furie K. Acute ischemic stroke associated with myocardial infarction: challenges and management. Semin Neurol. 2021;41(4):331–339. PMID: 33851390 https://doi.org/10.1055/s-0041-1726333
5. Luo J, Li H, Qin X, Liu B, Zhao J, Maihe G, et al. Increased risk of ischemic stroke associated with new-onset atrial fibrillation complicating acute coronary syndrome: a systematic review and metaanalysis. Int J Cardiol. 2018;265:125–131. PMID: 29706432 https://doi.org/10.1016/j.ijcard.2018.04.096
6. Chichkova MA, Kozlova OS, Adzhigitov AY, Chichkov AM. Clinical predictors of acute ischemic stroke in patients with acute myocardial infarction. Modern problems of science and education. 2016;(5). Available at: https://science-education.ru/ru/article/view?id=25328 [Accessed October 2, 2023]. (In Russ.).
7. Chichkova MA, Kozlova OS, Orlov FV. Features of the combination of myocardial infarction and acute cerebrovascular accident. Astrakhan medical journal. 2016;11(1):55–63. (In Russ.).
8. Chiang CH, Hung WT, Huang WC, Jheng YC, Lai WY, Lin YY, et al. The risk of stroke after acute myocardial infarction in patients with and without atrial fibrillation: a nationwide cohort study. J Chin Med Assoc. 2021;84(12):1126– 1134. PMID: 34898532 https://doi.org/10.1097/JCMA.0000000000000631
9. Yusuf S, Hawken S, Ounpuu S, Dans T, Avezum A, Lanas F, et al.; INTERHEART Study Investigators. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case control study. Lancet. 2004;364(9438):937–952. PMID: 15364185 https://doi.org/10.1016/S0140-6736(04)17018-9
10. Gerasimova YA. Chelysheva IA, Kuz'mina MS, Bunina IS, Early rehabilitation of patients with cardioembolic ischemic stroke on the background of coronary artery disease with heart rhythm disturbance. Bulletin of the Ivanovo Medical Academy. 2014;19(2):89–90. (In Russ.).
11. Rumyantseva SA, Oganov RG, Silina EV, Stupin VA, Bolevich SB, Svishcheva SP, et al. Modern concepts of treatment of patients with vascular comorbidity Part 1. Correction of tissue energy deficiency. Cardiovascular therapy and prevention. 2012;11(6):44–49. (In Russ.). https://doi.org/10.15829/1728-8800-2012-6-44-49
12. Salzwedel A, Heidler MD, Haubold K, Schikora M, Reibis R, Wegscheider K, et al. Prevalence of mild cognitive impairment in employable patients after acute coronary event in cardiac. Vasc Health Risk Manag. 2017;13:55–60. https://doi.org/10.2147/VHRM.S121086
13. Dubenko OE, Rakova IA. Stroke and cardiac dysfunction. Emergency medicine. 2011;1–2(32–33):10–16. (In Russ.).
14. Barber M, Morton JJ, Macfarlane PW, Barlow N, Roditi G, Stott DJ. Elevated troponin levels are associated with sympathoadrenal activation in acute ischaemic stroke. Cerebrovasc Dis. 2007;23(4):260–266. PMID: 17199083 https://doi.org/10.1159/000098325
15. Fan Y, Jiang M, Gong D, Man C, Chen Y. Cardiac troponin for predicting all-cause mortality in patients with acute ischemic stroke: a meta-analysis. Biosci Rep. 2018;38(2):BSR20171178. PMID: 29437906 https://doi.org/10.1042/BSR20171178
16. Bilalova RR, Ibragimova GZ, Zaytseva AR, Koroleva EM, Iskhakova AR. Experience in the treatment of combined pathol ogy of acute cerebrovascular accident and myocardial infarction. Bulletin of modern clinical medicine. 2018;11(5):16–22. (In Russ.). https://doi.org/10.20969/VSKM.2018.11(5).16–22
17. Cameron OG. Delirium, depression, and other psychosocial and neurobehavioral issues in cardiovascular disease. Crit Care Clin. 2007;23(4):881–900,viii. PMID: 17964368 https://doi.org/10.1016/j.ccc.2007.06.003
18. Gelfand BR, Linev DV, Yaroshetskiy AI, Protsenko DN, Krasnov VG, Krasnov VN. Delirium in critically ill patients: criteria for assessing severity, prognosis, treatment. Annals of Surgery. 2016;21(1–2):60–73. (In Russ.). https://doi.org/10.18821/1560-9502-2016-21-160-73
19. Grosmaitre P, Le Vavasseur O, Yachouh E, Courtial Y, Jacob X, Meyran S, et al. Significance of atypical symptoms for the diagnosis and management of myocardial infarction in elderly patients admitted to emergency departments. Arch Cardiovasc Dis. 2013;106(11):586–592. PMID: 24200926 https://doi.org/10.1016/j.acvd.2013.04.010
20. Kartasheva ED, Zamyatin MN. Delirium in patients with acute coronary syndrome: prevalence, causes, clinical significance. Clinical pathophysiology. 2016;22(1):34–39. (In Russ.).
21. Jäckel M, Zotzmann V, Wengenmayer T, Duerschmied D, Biever PM, Spieler D, Incidence and predictors of delirium on the intensive care unit after acute myocardial infarction, insight from a retrospective registry. Catheter Cardiovasc Interv. 2021;98(6):1072–1081. PMID: 32926556 https://doi.org/10.1002/Ccd.29275
22. Patil S, Gonuguntala K, Rojulpote C, Kumar M, Corradi JP, Chen K. Delirium is an important predictor of mortality in elderly patients with ST-elevation myocardial infarction: insight from National Inpatient Sample database. Coron Artery Dis. 2020;31(8):665-670. PMID: 33060523 https://doi.org/10.1097/MCA.0000000000000978
23. Abdullah A, Eigbire G, Salama A, Wahab A, Awadalla M, Hoefen R, et al. Impact of delirium on patients hospitalized for myocardial infarction: a propensity score analysis of the National Inpatient Sample. Clin Cardiol. 2018;41(7):910–915. PMID: 29717509 https://doi.org/10.1002/clc.22972
24. Pollock JS, Hollenbeck RD, Wang L, Holmes B, Young MN, Peters M, et al. Delirium in survivors of cardiac arrest treated with mild therapeutic hypothermia. Am J Crit Care. 2016;25(4):e81–89. PMID: 27369041 https://doi.org/10.4037/ajcc2016581
25. Honda S, Nagai T, Sugano Y, Okada A, Asaumi Y, Aiba T, et al.; NaDEF investigators. Prevalence, determinants, and prognostic significance of delirium in patients with acute heart failure. Int J Cardiol. 2016;222:521–527. PMID: 27509220 https://doi.org/10.1016/j.ijcard.2016.07.236
26. Ibrahim K, McCarthy CP, McCarthy KJ, Brown CH, Needham DM, Januzzi JL Jr, et al. Delirium in the cardiac intensive care unit. J Am Heart Assoc. 2018;7(4):e008568. PMID: 29453307 https://doi.org/10.1161/JAHA.118.008568
27. Linev DV, Yaroshetskiy AI, Protsenko DN, Gelfand BR. Efficacy and safety of dexmedetomidine, haloperidol and diazepam in the treatment of delirium: a comparative study. Anesthesiology and resuscitation. 2017;62(6):442–448. (In Russ.). https://doi.org/10.18821/0201-7563-2017-62-6442-448
28. Eremenko AA, Chernova EV. The use of dexmedetomidine for intravenous sedation and treatment of delirium in the early postoperative period in cardiac surgery patients. Anesthesiology and resuscitation. 2013;5:4–8. (In Russ.).
29. Serpytis P, Navickas P, Lukaviciute L, Navickas A, Aranauskas R, Serpytis R, et al. Gender-based differences in anxiety and depression following acute myocardial infarction. Arq Bras Cardiol. 2018;111(5):676–683. PMID: 30156607 https://doi.org/10.5935/abc.20180161
30. Echols MR, O'Connor CM. Depression after myocardial infarction. Curr Heart Fail Rep. 2010;7(4):185–193. PMID: 20730574 https://doi.org/10.1007/s11897-010-0024-6
31. Shapiro PA. Management of depression after myocardial infarction. Curr Cardiol Rep. 2015;17(10):80. PMID: 26277362 https://doi.org/10.1007/s11886-015-0634-4
32. Levine DA, Langa KM, Galecki A, Kabeto M, Morgenstern LB, Zahuranec DB, et al. Mild cognitive impairment and receipt of treatments for acute myocardial infarction in older adults. J Gen Intern Med. 2020;35(1):28– 35. https://doi.org/10.1007/s11606-019-05155-8
33. Preobrazhenskaya IS. NMDA receptor antagonists in the treatment of patients with vascular cognitive impairment. Neurology, neuropsychiatry, psychosomatics. 2014;6(2S):69–74. (In Russ.). https://doi.org/10.14412/20742711-2014-2S-69-74
Review
For citations:
Muradyan N.A., Kuzmina I.M., Gvindzhiliya T.R., Balanyan V.M., Popugaev K.A. Cerebral dysfunction in patients with acute myocardial infarction. Transplantologiya. The Russian Journal of Transplantation. 2023;15(4):507-514. https://doi.org/10.23873/2074-0506-2023-15-4-507-514